Yuanzhou Wang
Key Laboratory Of Medical Molecular Virology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or Mpro inhibitors.
Journal: Journal of virology
Published: March 30, 2026
A VLP-based mRNA vaccine elicits potent humoral and cellular immunity against Oropouche virus.
Journal: mBio
Published: January 12, 2026
A highly potent, stable, and safe dePEGylated lipopeptide against Nipah virus and related henipaviruses.
Journal: Emerging microbes & infections
Published: December 29, 2025
Potent Inhibition of Human Betacoronaviruses by a Short Double-Stapled Peptide Mimicking the HR2 Core Region in Viral Spike Protein.
Journal: Journal of medicinal chemistry
Published: August 22, 2025
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.
Journal: Nature nanotechnology
Published: August 05, 2025
Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategies.
Journal: Current research in microbial sciences
Published: April 03, 2025
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.
Journal: MedComm
Published: September 18, 2024
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD.
Journal: Cell reports. Medicine
Published: November 01, 2023
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 10, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026